NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search

Intarcia Therapeutics Inc.

Intarcia Therapeutics is developing a continuous subcutaneous delivery system for the treatment of Type 2 diabetes. The RTP location discovers and develops peptide therapeutic drugs to augment Intarcia's drug delivery platform.

Company location

6 Davis Drive
Research Triangle Park, NC 27709

P.O. Box 14230
Research Triangle Park, NC 27709
Phone 
(919) 282-3801
County 
Durham
Region 
Triangle

Company Classification

Company type 
Bioscience Company
Year founded 
2015
Employment in NC 
1-19
US headquarters 
Massachusetts
Global headquarters 
United States
Company activities 
Research and Development
Products under development 
1. ITCA 650 (type 2 diabetes, regulatory approval stage); 2. ITCA 349 + ITCA 650 (obesity, preclinical development stage)